Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Exploring the Difficulties of Beginning a Family: Individual Experiences- The Delight of Perusing: Book Proposals for Each Class
- 80 km. on foot: Sharren Haskel’s three-day march in protest of haredi draft bill
- Malaysia To Revive Search for Missing Flight MH370
- 5 Wellbeing Applications Assist You With remaining Fit
- Astonishing Deserts All over The Planet You Really want To Visit
- The Main 15 Applications for Efficiency and Association
- The most effective method to Look at Medical caretaker Compensations Across Various Clinics
- Manual for Financial plan Agreeable PC
